logo-loader
Avacta Group PLC

Turner Pope Investor Evening

/**/ sup{font-size:80%}p{margin-right:0cm;margin-left:0cm;font-size:10.0pt;font-family:Times;}ol{margin-bottom:0cm;}ul{margin-bottom:0cm;}link{ color: blue }visited{ color: purple } .bd{size:595.0pt 842.0pt;margin:69.25pt 42.15pt 49.65pt 70.9pt;}div.bd{}p.df{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;font-size:12.0pt;font-family:"Cambria","serif";margin-top:0cm;margin-right:9.2pt;margin-bottom:0cm; margin-left:0cm;margin-bottom:.0001pt;line-height:115%}span.dd{font-size:11.0pt;line-height:115%;font-family:"Arial","sans-serif"}p.dg{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;font-size:12.0pt;font-family:"Cambria","serif";line-height: 115%; margin-bottom: 0cm; text-align: right}span.db{font-size:11.0pt; line-height:115%;font-family:"Arial","sans-serif"}p.dh{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;font-size:12.0pt;font-family:"Cambria","serif";font-weight: bold; margin-bottom: 0cm; text-align: center}span.cy{font-size:11.0pt;font-family: "Arial","sans-serif"}span.cz{color:black}p.di{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;font-size:12.0pt;font-family:"Cambria","serif";margin-bottom: 0cm; text-align: center} span.cw{font-size:11.0pt;font-family:"Arial","sans-serif"; color:black}p.dj{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;font-size:12.0pt;font-family:"Cambria","serif";font-weight: bold; line-height: 12.65pt; margin-bottom: 0cm; text-align: center}span.cu{font-size: 11.0pt;font-family:"Arial","sans-serif";color:black}p.dk{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;font-size:12.0pt;font-family:"Cambria","serif";line-height: 12.65pt; margin-bottom: 0cm; text-align: center}span.cs{font-size:11.0pt; font-family:"Arial","sans-serif";color:black}p.dl{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;font-size:12.0pt;font-family:"Cambria","serif";margin-bottom:0cm;margin-bottom:.0001pt;text-align: justify;text-justify:inter-ideograph}span.ai{}span.dm{background:white}span.dn{background: white}span.do{font-size:11.0pt; font-family:"Arial","sans-serif";color:black} span.cn{font-size:11.0pt;font-family:"Arial","sans-serif";color:black}p.dp{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;font-size:12.0pt;font-family:"Cambria","serif";font-weight: bold; line-height: 115%; margin-bottom: 0cm; text-align: justify; text-justify: inter-ideograph}span.cm{font-size:10.0pt;line-height:115%;font-family:"Arial","sans-serif"}p.dq{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;font-size:12.0pt;font-family:"Cambria","serif";font-weight: bold; line-height: 115%; margin-bottom: 0cm; text-align: center}span.ck{font-size:10.0pt; line-height:115%;font-family:"Arial","sans-serif"}p.dr{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;font-size:12.0pt;font-family:"Cambria","serif";font-weight: bold; line-height: 115%; margin-bottom: 0cm}span.ci{font-size:10.0pt;line-height:115%;font-family: "Arial","sans-serif"}p.ds{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;font-size:12.0pt;font-family:"Cambria","serif";font-weight: bold; line-height: 115%}table.dt{width:440.9pt;margin-left:-5.4pt;border-collapse:collapse}td.cb{width:230.7pt;padding:0cm 5.4pt 0cm 5.4pt} p.du{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;font-size:12.0pt;font-family:"Cambria","serif";font-weight: bold; line-height: 115%; margin-bottom: 0cm; margin-left: 14.2pt; margin-right: 0cm; margin-top: 0cm}span.cf{font-size:10.0pt;line-height:115%;font-family:"Arial","sans-serif"; color:black}p.dv{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;font-size:12.0pt;font-family:"Cambria","serif";margin-top:0cm;margin-right:0cm;margin-bottom:0cm; margin-left:14.2pt;margin-bottom:.0001pt;line-height:115%}p.dw{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";font-weight: bold; line-height: 115%; margin-bottom: 0cm; margin-left: 14.2pt; margin-right: 9.2pt; margin-top: 0cm}td.bx{width:188.6pt;padding:0cm 5.4pt 0cm 5.4pt}p.dx{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;font-size:12.0pt;font-family:"Cambria","serif";margin-top:0cm;margin-right:0cm;margin-bottom:0cm; margin-left:14.2pt;margin-bottom:.0001pt;text-align:justify;text-justify: inter-ideograph;line-height:115%}span.ca{font-size:10.0pt; line-height:115%;font-family:"Arial","sans-serif";color:black}p.dy{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";margin-top:0cm;margin-right:9.2pt;margin-bottom:0cm; margin-left:14.2pt;margin-bottom:.0001pt;text-align:justify;text-justify: inter-ideograph;line-height:115%}span.bw{font-size:10.0pt;line-height: 115%;font-family:"Arial","sans-serif";color:black}span.bv{font-size:10.0pt;line-height: 115%;font-family:"Arial","sans-serif"} p.dz{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;font-size:12.0pt;font-family:"Cambria","serif";margin-top:0cm;margin-right:9.2pt;margin-bottom: 0cm;margin-left:14.2pt;margin-bottom:.0001pt;line-height:115%}p.ea{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;font-size:12.0pt;font-family:"Cambria","serif";line-height: 115%; margin-bottom: 0cm; margin-left: 14.2pt; margin-right: 0cm; margin-top: 0cm; text-align: justify; text-decoration: underline; text-justify: inter-ideograph}span.eb{font-family:"Times New Roman","serif";color:blue;text-decoration:underline;color: black; font-family: "Arial","sans-serif"; font-size: 10.0pt; line-height: 115%; text-decoration: none}p.ec{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;font-size:12.0pt;font-family:"Cambria","serif";font-weight: bold; margin-bottom: 0cm; margin-left: 14.2pt; margin-right: 0cm; margin-top: 0cm}span.br{font-size:10.0pt;font-family:"Arial","sans-serif"}p.ed{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;font-size:12.0pt;font-family:"Cambria","serif";margin-top:0cm;margin-right:0cm;margin-bottom:0cm; margin-left:14.2pt;margin-bottom:.0001pt}span.bp{font-size: 10.0pt;font-family:"Arial","sans-serif"}p.ee{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;font-size:12.0pt;font-family:"Cambria","serif";margin-top:0cm;margin-right:0cm;margin-bottom:0cm; margin-left:14.2pt;margin-bottom:.0001pt;text-align:justify;text-justify: inter-ideograph}p.ef{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;font-size:12.0pt;font-family:"Cambria","serif";margin-bottom: 0cm; margin-left: 14.2pt; margin-right: 0cm; margin-top: 0cm; text-align: justify; text-decoration: underline; text-justify: inter-ideograph}span.bm{font-size:10.0pt;font-family: "Arial","sans-serif"} span.bk{font-size:10.0pt; line-height:115%;font-family:"Arial","sans-serif";color:windowtext}span.bj{font-size: 10.0pt;line-height:115%;font-family:"Arial","sans-serif";color:windowtext}p.eg{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;font-size:12.0pt;font-family:"Cambria","serif";margin-right:9.2pt;line-height:115%}p.eh{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;font-size:12.0pt;font-family:"Cambria","serif";margin-bottom:0cm;margin-bottom:.0001pt;text-align: justify;text-justify:inter-ideograph;line-height:115%}span.bg{font-size: 10.0pt;line-height:115%;font-family:"Arial","sans-serif";color:black}span.be{color: blue; text-decoration: underline} /**/
RNS Number : 6749C
Avacta Group PLC
19 June 2019
 

 

19 June 2019

 Avacta Group plc

("Avacta", the "Company" or the "Group")

 

Turner Pope Investor Evening

 

Avacta Group plc (AIM: AVCT.L), the developer of Affimer® biotherapeutics and reagents, is pleased to announce that the Group's Chief Executive, Alastair Smith, will be presenting at an investor evening hosted by Turner Pope Investments on Wednesday, 3 July 2019. The event will be held in London, EC2 and commence at 4pm.

 

To register your interest, please email [email protected] or call on 0203 621 4124.

 

- Ends -

 

 

 

For further information from Avacta Group plc, please contact:

Avacta Group plc

Alastair Smith, Chief Executive Officer

Tony Gardiner, Chief Financial Officer

 

Tel:  +44 (0) 844 414 0452

www.avacta.com

finnCap Ltd (Nominated Adviser and Joint Broker)

Geoff Nash / Giles Rolls - Corporate Finance

Tim Redfern - ECM

 

WG Partners (Joint Broker)

Nigel Birks / Nigel Barnes

David Wilson / Claes Spang

 

Tel:  +44 (0) 207 220 0500

www.finncap.com

 

 

Tel:  +44 (0) 203 705 9318

Tel:  +44 (0) 203 705 9217

www.wgpartners.co.uk

 

Turner Pope Investments

James Pope / Ben Turner

 

Yellow Jersey PR (Financial Media and IR)

Sarah Hollins

Harriet Jackson

 

Zyme Communications (Trade and Regional Media)

Katie Odgaard

Tel: +44 (0) 203 621 4120

www.turnerpope.com

 

 

Tel: +44 (0)7764 947 137

Tel: +44 (0)7544 275 882

[email protected]

 

Tel: +44 (0)7787 502 947

[email protected] 

 

About Avacta Group plc - https://www.avacta.com

Avacta's principal focus is on its proprietary Affimer® technology which is a novel engineered alternative to antibodies that has wide application in Life Sciences for diagnostics, therapeutics and general research and development.

 

Antibodies dominate markets worth in excess of $100bn despite their shortcomings.  Affimer technology has been designed to address many of these negative performance issues, principally; the time taken to generate new antibodies, the reliance on an animal's immune response, poor specificity in many cases, and batch to batch variability.  Affimer technology is based on a small protein that can be quickly generated to bind with high specificity and affinity to a wide range of protein targets.

 

Avacta has a pre-clinical biotech development programme with an in-house focus on immuno-oncology as well as partnered development programmes.  Avacta is commercialising non-therapeutic Affimer reagents through licensing to developers of life sciences research tools and diagnostics. 

 

To register for news alerts by email go to www.avacta.com/investor-news-email-alerts


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
NRALLFFRRIITLIA

Quick facts: Avacta Group PLC

Price: £0.21

Market: AIM
Market Cap: £24.39 m
Follow

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Investor Update: Green light for ValiRx to increase dose of VAL201

Top stories from the Proactive Investors UK newsroom. ValirX (LON:VAL) has received a boost for its prostate cancer treatment VAL201 after UK regulators approved a substantial increase in the doses allowed in future clinical trials. The phase I/II trial so far has met all primary and...

on 20/6/19